Alternative splicing of ALDOA confers tamoxifen resistance in breast cancer.
Yu S, Wu R, Si Y, Fan Z, Wang Y, Yao C, Sun R, Xue Y, Chen Y, Wang Z, Dong S, Wang N, Ling X, Liang Z, Bi C, Yang Y, Dong W, Sun H.
Yu S, et al. Among authors: si y.
Oncogene. 2024 Sep;43(39):2901-2913. doi: 10.1038/s41388-024-03134-w. Epub 2024 Aug 20.
Oncogene. 2024.
PMID: 39164523